Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 76,553 |
|
|||||
| News | - | ||||||
| Day High | 8.61 | Low High |
|||||
| Day Low | 8.36 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Arcutis Biotherapeutics Inc | ARQT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.085 | -0.99% | 8.505 | 08:37:21 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 8.59 | 8.36 | 8.61 | 8.59 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 476 | 76,553 | US$ 8.54 | US$ 654,061 | - | 1.76 - 15.21 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 08:37:21 | 25 | US$ 8.50 | USD |
Arcutis Biotherapeutics (ARQT) Options Flow Summary
Arcutis Biotherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 814.2M | 96.81M | - | 59.61M | -262.14M | -2.71 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Arcutis Biotherapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARQT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.36 | 9.455 | 8.21 | 8.88 | 2,293,994 | -0.855 | -9.13% |
| 1 Month | 9.96 | 13.17 | 8.21 | 10.48 | 2,835,162 | -1.46 | -14.61% |
| 3 Months | 6.66 | 13.17 | 5.38 | 9.70 | 4,053,504 | 1.85 | 27.70% |
| 6 Months | 2.25 | 13.17 | 1.76 | 5.86 | 4,674,648 | 6.26 | 278.00% |
| 1 Year | 13.51 | 15.21 | 1.76 | 6.18 | 3,071,875 | -5.01 | -37.05% |
| 3 Years | 29.06 | 36.45 | 1.76 | 9.14 | 1,337,262 | -20.56 | -70.73% |
| 5 Years | 23.05 | 40.88 | 1.76 | 10.19 | 998,291 | -14.55 | -63.10% |
Arcutis Biotherapeutics Description
| Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate, roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. |
